How effective is radiotherapy for inflammatory breast cancer?

Inflammatory breast cancer can involve a broad area of breast skin and lymphatic channels. Treatment commonly combines whole-body medicines with surgery and local radiotherapy, because each part addresses a different aspect of the disease. Radiotherapy may cover the chest wall and selected lymph-node regions after surgery, based on the original disease and findings at surgery. The aim is local control and reducing the chance that cells remain in those tissues.

The expected benefit cannot be judged from breast redness or swelling alone. The team reviews examination findings, imaging, response to medicines, surgical results, lymph-node involvement, and tumour biology. The field is planned to balance coverage with protection of the heart, lungs, and nearby skin.

Discuss the sequence of medicines, surgery, and radiotherapy, including when wound healing is expected to be adequate. Tell the team about breast or chest pain, arm swelling, reduced shoulder movement, heart or lung conditions, and any possibility of pregnancy. Ask about skin moisturising, movement exercises, clothing, and when to seek help for wound changes. Attend follow-up visits so skin, arm movement, swelling, and breathing symptoms can be assessed.

Contact the team promptly for spreading redness, drainage, wound opening, fever, severe skin breakdown, new arm swelling, or worsening shortness of breath. Seek emergency care for sudden severe breathlessness, chest pain, fainting, or signs of a serious allergic reaction. Early assessment can help distinguish infection, healing problems, lymphoedema, and treatment effects.

Which tissues and lymph-node regions will be treated? How did my response to medicines and surgical findings affect the recommendation? How will the plan protect my heart and lungs? What skin, shoulder, and arm changes should I report?